Mercado global de tratamento de doenças de Hirschsprung – Tendências do setor e previsão para 2028

Análise de mercado e insights: mercado global de tratamento de doenças de Hirschsprung

Espera-se que o mercado de tratamento de doenças de Hirschsprung ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 4,30% no período de previsão de investigação acima referido. Aumento das doenças cardiovasculares e aumento da prevalência da doença de Hirschsprung em todo o mundo.

O grande número de anomalias associadas, incluindo a síndrome de Down, entre outras, e o aumento da taxa de diagnóstico para alcançar um tratamento eficaz também impulsionam o crescimento do mercado. Além disso, o aumento da parceria e colaboração entre os participantes do mercado e o aumento das iniciativas governamentais para manter uma melhor saúde da população infantil funcionam como uma oportunidade para o crescimento do mercado. Mas a falta de opções de tratamento definitivo, o diagnóstico incorreto da doença e o acesso limitado aos serviços de saúde podem dificultar o mercado global de tratamento da doença de Hirschsprung.

Hirschsprung’s disease causes absence of nerves from some parts of the intestine. This disease is mostly diagnosed during development before birth, mostly identified during the first two months of life. Hirschsprung’s disease is further classified into two types depending upon the region of intestine which lacks the nerves. These two types include short-segment disease and long-term segment. In short-segment Hirschsprung’s disease nerves have been reported missing from only the last segment of large intestine while in long-segment Hirschsprung’s disease nerve cells are missing from most of the large intestine part. The most common types of Hirschsprung’s disease is short-segment disease and accounts for 80% of people suffering from Hirschsprung’s disease. However short-segment Hirschsprung’s disease affects only 20% of sufferers. Hirschsprung’s disease has been reported to occur with other types of disease combinations including Mowat-Wilson syndrome, Waardenburg syndrome or congenital central hypoventilation syndrome among others. Hirschsprung’s disease can be treated by medications including antibiotics, toxins among others. In severe cases surgical treatment suggested, however due to invasive nature most of the affected population prefers medication treatment approach.

The prevalence of Hirschsprung’s disease is increasing worldwide with reported prevalence of 1 in every 5,000 live births. Moreover this has also been reported that Hirschsprung’s disease is associated with several other complications including Down syndrome, dominant sensorineural deafness, Waardenburg syndrome, neurofibromatosis, neuroblastoma, ganglioneuroma, ganglioneuroblastoma, retinoblastoma, and tumors,  which raises the demands of development of effective treatment approaches to deal with such and hence expected to provide market with the lucrative growth.

This Hirschsprung’s disease treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Hirschsprung’s Disease Treatment Market Scope and Market Size

Hirschsprung’s disease treatment market is segmented on the basis of treatment, gender, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the Hirschsprung’s disease treatment market is segmented into surgery and medication. Medication segment is further sub-segmented into antibiotics, toxins and others. Antibiotics segment is further sub-segmented into ampicillin, gentamicin and metronidazole among others.
• On the basis of gender, the Hirschsprung’s disease treatment market is segmented into male and female.
• On the basis of route of administration, the Hirschsprung’s disease treatment market is segmented into oral, parenteral, others.
• On the basis of end-users, the Hirschsprung’s disease treatment market is segmented into pediatric clinics, hospitals, homecare, others.
• On the basis of distribution channel, the Hirschsprung’s disease treatment market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, others. 

Hirschsprung’s Disease Treatment Market Country Level Analysis

Hirschsprung’s disease treatment market is analysed and market size information is provided by country, treatment, gender, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Hirschsprung’s disease treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to rise in prevalence of Hirschsprung’s disease in U.S, as approximately 1 in every 5400-7200 new borns are affected. Moreover adoption of various treatment modalities is another factor driving the market growth. Europe accounts the second largest market share due to wide drug distribution network and growing awareness towards intestinal diseases. Asia-Pacific is expected to account for the largest market share over coming years for the Hirschsprung’s disease treatment market due to continuous development in health and pharmaceutical industries and rising investment in emerging economies.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações nas regulamentações do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como novas vendas, vendas de reposição, demografia do país, epidemiologia de doenças e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornece uma análise de previsão dos dados do país.

Análise Epidemiológica do Doente

O mercado de tratamento de doenças de Hirschsprung também fornece análises de mercado detalhadas para análise de pacientes, prognóstico e curas. Prevalência, incidência, mortalidade, taxas de adesão são algumas das variáveis ​​de dados disponíveis no relatório. As análises de impacto direto ou indireto da epidemiologia para o crescimento do mercado são analisadas para criar um modelo estatístico multivariado mais robusto e de coorte para prever o mercado no período de crescimento.

Análise do panorama competitivo e da quota de mercado do tratamento da doença de Hirschsprung

O panorama competitivo do mercado de tratamento de doenças de Hirschsprung fornece detalhes por concorrente, os detalhes incluídos são a visão geral da empresa, finanças da empresa, receita gerada, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, locais e instalações de produção, pontos fortes e fracos da empresa, lançamento do produto, pipelines de ensaios clínicos, aprovações de produtos, patentes, largura e amplitude do produto, domínio da aplicação, curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de tratamento de doenças de Hirschsprung.

Os principais players abrangidos no mercado de tratamento da doença de Hirschsprung são a Pfizer Inc., Sanofi, Johnson & Johnson Services, Inc., Novartis AG, Merck KGaA, Bristol-Myers Squibb, Astellas Pharma, Inc., Eli Lilly and Company, Abbott , Panacea Biotech Ltd., Cipla Ltd., GlaxoSmithKline, Dr. Reddy's Laboratories Ltd., Baxter International, Wuhan Wuyao Pharmaceutical Co.,ltd, Hubei Hongyuan Pharmaceutical technology Co.,Ltd., CordenPharma International, AbbVie entre outros players nacionais e globais . Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-60214